Discussion on the molecular mechanism of genistein therapy for depression based on network pharmacology#br#
HU Yanzhen1 ZHANG Yuanyuan1 HUANG Bin1 WANG Yamin1 CHEN Le1▲ YANG Zhi2
1.Institute of Chinese Materia Medica, Jiangxi Provincial Institute of Traditional Chinese Medicine, Jiangxi Province, Nanchang 330046, China;
2.Department of Neonatal Surgery, Jiangxi Provincial Children’s Hospital, Jiangxi Province, Nanchang 330006, China
Abstract:Objective To systematically explore the key targets and molecular mechanisms of genistein in the treatment of depression based on network pharmacology. Methods The traditional Chinese medicine systems pharmacology database and analysis platform, comparative toxicogenomics, TTD, GeneCards, Home-NCBI-Gene and other databases were used to obtain the related targets of genistein in the treatment of depression. Protein-protein interaction (PPI) and “component-target-disease” network diagrams were constructed, and key targets were screened according to PPI interaction network diagrams. DAVID database was used to analyze the GO and KEGG pathways of target protein genes. Results Six key targets including MAPK1, PTGS2, MMP9, VEGFA, AKT1 and TNF, were identified by screening. A total of 33 GO functional information were obtained, including positive regulation of cell division, protein kinase B signal transduction, positive regulation of serine peptide phosphorylation, positive and negative regulation of RNA polymerase Ⅱ promoter transcription, immune response, positive regulation of MAP kinase activity, positive regulation of cell proliferation, blood glucose homeostasis, angiogenesis, positive regulation of NF-κB signal, etc. KEGG pathway enrichment analysis screened 23 signaling pathways, mainly involving cancer, immune inflammatory response, apoptosis, viral infection, etc. Conclusion Genistein has “multi-target-multi-pathway” regulation in the treatment of depression. This study provides a new idea for the molecular mechanism verification of genistein’s anti-depression.
胡燕珍1 张媛媛1 黄斌1 王亚敏1 陈乐1▲ 杨治2. 基于网络药理学探讨染料木素治疗抑郁症的分子作用机制[J]. 中国医药导报, 2021, 18(32): 138-142,150.
HU Yanzhen1 ZHANG Yuanyuan1 HUANG Bin1 WANG Yamin1 CHEN Le1▲ YANG Zhi2. Discussion on the molecular mechanism of genistein therapy for depression based on network pharmacology#br#. 中国医药导报, 2021, 18(32): 138-142,150.